TCL Archive The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says May 7, 1999
TCL Archive FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer October 20, 1995
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official June 27, 1980
TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986
